Glaucoma is a multifactorial optic neuropathy characterized by retinal ganglion cell (RGC) death and axonal degeneration leading to irreversible blindness. Mutations in the MYOCILIN (MYOC) gene are the most common genetic factors of primary open-angle glaucoma. To develop a genetic mouse model induced by the synergistic interaction of mutated myocilin and another significant risk factor, oxidative stress, we produced double-mutant mice (Tg-MYOC Y437H/+ /Sod2 +/− ) bearing human MYOC with a Y437H point mutation and a heterozygous deletion of the gene for the primary antioxidant enzyme, superoxide dismutase 2 (SOD2). Sod2 is broadly expressed in most tissues including the trabecular meshwork (TM) and heterozygous Sod2 knockout mice exhibit the reduced SOD2 activity and oxidative stress in all studied tissues. Accumulation of Y437H myocilin in the TM induced endoplasmic reticulum stress and led to a 45% loss of smooth muscle alpha-actin positive cells in the eye drainage structure of 10-to 12-month-old Tg-MYOC /Sod2 +/− mice. This is the first reported animal glaucoma model that combines expression of a glaucomacausing mutant gene and an additional mutation mimicking a deleterious environment factor that acts synergistically.
Introduction
Glaucoma is a progressive optic neuropathy characterized by retinal ganglion cell (RGC) death, degeneration of axons in the optic nerve, and specific deformation of the optic nerve head (ONH) known as glaucomatous cupping (1) . Primary open-angle glaucoma (POAG) is the most common form of glaucoma, with elevated intraocular pressure (IOP) being one of the main risk factors (2) . Globally, more than 70 million people suffer from glaucoma, rendering it the second leading cause of blindness in the world. Since glaucoma prevalence increases with age, the number of glaucoma patients is expected to increase as the human life span continues to lengthen (1, 3) . Despite the high prevalence and severity of glaucoma, the biological basis of glaucoma is poorly understood and the factors contributing to its progression have not yet been fully elucidated.
The contribution of genetic variations to the development of POAG has been proven and disease-associated genes identified (4, 5) . Among them, the first identified and most commonly studied gene is MYOCILIN (MYOC), which encodes a glycoprotein consisting of 504 amino acids in humans. Mutations in MYOC are responsible for approximately 3-5% of adult-onset POAG and 10-30% of juvenile-onset open-angle glaucoma (5) (6) (7) . So far, more than 70 different glaucoma-associated mutations have been identified in MYOC, and the majority of these mutations are within the third exon of the gene encoding the olfactomedin domain at the carboxyl terminus of the protein (8, 9) . Diseasecausing mutant myocilins are non-secreted (10) , relatively insoluble (11) , form intracellular aggregates containing amyloid fibrils (12) , and are accumulated in ER as aggregates leading to ER stress, which ultimately may lead to cell death (13) (14) (15) (16) (17) . Myocilin is abundantly expressed in the trabecular meshwork (TM), one of the key components of the eye's aqueous humor outflow system (18, 19) . This suggests that accumulation of mutated myocilin in TM could lead to ER stress, and ultimately may result in the loss of cells within the TM, structural changes in the outflow pathway, and elevated IOP (16, 17) . Several transgenic mouse lines expressing mutated mouse or human myocilin in the TM have been generated to produce a mouse glaucoma model, allowing a better understanding of the in vivo pathogenic mechanisms induced by mutated myocilin (20) (21) (22) (23) . We have generated transgenic mice using a bacterial artificial chromosome containing the full-length human MYOC gene with the Y437H point mutation. These mice produced physiological levels of mutated Y437H human myocilin in the iridocorneal angle tissues (20) . The expressed mutant myocilin accumulated in the TM and led to up-regulation of ER stress markers and down-regulation of paraoxonase 2 and glutathione peroxidase 3 in the eye angle tissues of aged (16-month-old) transgenic mice that help to defend against oxidative stress (16) . However, moderate IOP elevation and loss of RGCs in the peripheral retina were detected only in aged (16-to 18-month-old) mice. Expression of the same human Y437H mutant myocilin at much higher level in the TM of transgenic mice using the CMV promoter led to more dramatic elevation of IOP and RGC loss that could be detected even in 3-to 5-month-old mice (23) .
Available data suggest that interactions between genetic and environmental factors confer the complex disease phenotypes of POAG (24) (25) (26) (27) . This implies that individuals carrying POAG-associated genetic variants of certain genes may be more susceptible to the development of the disease when they are exposed to particular environmental factors. Environmental factors and unhealthy lifestyles-like atmospheric pollutants, cigarette smoke, ultraviolet rays, radiation, and toxic chemicals-can create an imbalance between pro-oxidants and antioxidants, leading to oxidative stress (28) . Oxidative and ER stress are intimately interconnected (29) . It has been shown that expression of mutated myocilin in primary TM cultures impairs mitochondrial functions (30) , while expression of mutated myocilin in HEK293 cells make them more sensitive to oxidative stress (16) . This led to a suggestion that TM of people carrying mutations in MYOC might be more sensitive to the oxidative stress produced by environmental factors.
Here, to test this hypothesis in an animal model, we applied oxidative stress to our transgenic mouse line that expresses the human Y437H myocilin mutant by mating this line with mice carrying a null mutation of Sod2 (superoxide dismutase 2). SOD2, a critical enzyme for aerobic life (31) , is a detoxification enzyme that converts superoxide to hydrogen peroxide, which can subsequently be converted to water. SOD2 is broadly expressed in most tissues including human TM cells and rat eye angle tissues (32, 33) . The homozygous Sod2 knockout mice survive only for a short time (34) . However, heterozygous Sod2 knockout mice exhibit an apparently normal phenotype and life span, despite the reduced activities of the enzyme and excessive oxidative stress in all studied tissues (35) . We report that mice that express human mutated myocilin in the TM and are heretozygous for the Sod2 null mutation develop more severe glaucoma-like phenotype much earlier than mice carrying just myocilin mutation. Pathogenic mechanisms activated in this double-mutant mouse model may better reflect the pathology observed in human patients carrying mutations in MYOC.
Results
Mutated myocilin and Sod2 haplodeficiency together induce elevated levels of apoptotic and ER stress markers in vivo
Since expression of mutated myocilin makes cells in culture more sensitive to oxidative stress, we hypothesized that in vivo expression of mutated myocilin in transgenic mice would similarly increase the sensitivity of TM cells to oxidative stress and promote cell death (16 suggests apoptotic cell death and TM damage. To evaluate TM damage in vivo, we stained TM with antibodies against alphasmooth muscle actin (α-SMA). In the eye, α-SMA expression was detected in the human aqueous outflow pathway (40) . Staining of the eye sections of wild-type mice with antibodies against α-SMA demonstrated specific staining of the junction of the cornea and iris corresponding to the TM area ( Fig. 2A) . α-SMA staining was co-localized with myocilin staining in the TM, though myocilin staining extended further into the sclera ( Fig. 2A) . Staining of the whole mouse eye ball with antibodies against α-SMA showed a very specific signal, located at the expected TM position, and extended around the whole eye (Fig. 2B ). For more careful examination of α-SMA staining, tissues around the TM were dissected (see a yellow square in Fig. 2B ) and the staining patterns were compared between different genotypes. Strong α-SMA staining was observed in the TM area of wild-type mice (Fig. 2C) Upper panel shows the bright-field images. Eye sections from at least three independent mice of each genotype were used for staining. Representative images are shown. Scale bar, 100 μm; TM, trabecular meshwork; CB, ciliary body.
Tg-MYOC Y437H/+ or wild-type mice between 8 and 12 months of age.
Tg-MYOC
Y437H/+ /Sod2 +/− mice also did not show statistically significant changes in IOP between 8-to 10-and 10-to 12-month-old age groups tested (now shown) and data for both groups were combined in Figure 3 . Statistically significant elevation of IOP was detected in 8-to 12-month-old Tg-MYOC 4A ). Less pronounced differences in the staining intensity were observed in the central retinas from mice of different genotypes ( Fig. 4A and C) . To determine whether the Tg-MYOC Up-regulation of ELAM-1 mRNA in the TM of glaucomatous donors has been also demonstrated by microarray analysis (45) , while a proteomic study demonstrated the presence of higher levels of ELAM-1 in the aqueous humor of POAG patients (46) . Increased expression of ELAM-1 also has been reported in the aqueous outflow pathway of an induced glaucoma model (47 Fig. 8A and B) . Thus, the mice expressing the Y437H mutant myocilin indeed have up-regulated expression of a well-accepted marker for glaucoma, and the up-regulation is enhanced in Tg-MYOC 
Discussion
Adult-onset POAG is a complicated disease that appears to be influenced by multiple genetic and environmental factors (5, 25) . To date, at least 20 genetic loci have been identified as being associated with POAG. MYOC is the first identified and most studied glaucoma gene. The MYOC absence apparently does not lead to glaucoma (48, 49) . Disease-causing mutations in myocilin likely act by a gain of function mechanism (49) . Available data suggest that myocilin-induced glaucoma can be a form of ER storage disease (23, 50, 51) and that disease pathogenesis in POAG patients depends upon the expression of abnormal mutated myocilin.
To study molecular mechanisms of myocilin-induced glaucoma, several mouse lines expressing Y437H human mutant myocilin or its corresponding mouse mutant, Y423H mouse mutant myocilin, in eye angle tissues have been produced. Two transgenic mouse lines expressing Y437H human mutant myocilin or its corresponding mouse mutant, Y423H mouse mutant myocilin have been generated using bacterial artificial chromosome DNA encoding the full-length human MYOC or mouse Myoc genes (20, 21) . These two mutant myocilin lines exhibited similar levels of pathological change, including approximately 2 mmHg higher IOP, a 20% loss of RGCs in the peripheral retina, and mild axonal degeneration in the optic nerve (20, 21) . In contrast to these results, replacement of the endogenous mouse Myoc allele with a mutant Y423H allele did not lead to an elevation of IOP and degenerative changes in the retina or optic nerve (22) . This might be explained by different genetic backgrounds of mice (52) and/or different levels of mutant myocilin produced. Indeed, expression of high levels of mutated human Y437H myocilin in the eye drainage structures and sclera under the control of the cytomegalovirus promoter in transgenic mice led to elevation of IOP by about 3 mmHg at 3 months of age (23) . This was accompanied by the loss of RGCs (about 18% by 3-5 months of age and 30% by 12-14 months of age) and optic nerve axons. Pathological changes observed in the eyes of mice expressing mutated myocilin are similar to those observed in glaucoma patients. However, pathological changes induced by the physiological levels of mutated myocilin are much less dramatic than the ones seen in human subjects with the same MYOC mutation. One possible explanation of the observed differences is that the conventional trabecular outflow pathway accounts for about 80% of aqueous humor removal in humans, while about 20% of aqueous humor leaves the eye through the Human Molecular Genetics, 2015, Vol. 24, No. 12 | 3329 unconventional uveoscleral pathway. In mice, oppositely, about 80% of aqueous humor leaves the eye through the uveoscleral pathway and only about 20% through the trabecular outflow pathway (53, 54) . Although mutations in MYOC are considered to be a significant genetic factor, severity of the disease in individuals bearing a deleterious MYOC mutation may be dependent upon other risk factors during their life time. Patients with the Y437H mutation in MYOC demonstrate a range of recorded IOP (14-77 mm Hg) with mean 44 mm Hg as well as age at diagnosis of disease years) with mean 20 years that is much earlier than typical age of non-MYOC-associated POAG (55) . Mice may not be exposed to the same risk factors as humans due to a different life style. Moreover, since mice have a much shorter life span than humans, they might not be exposed to the risk factors long enough to lead to the severe pathological changes that humans acquire. All the values are presented as mean ± SE. *P < 0.05; **P < 0.01. n shows the number of analyzed mice.
Therefore, to elevate pathological changes in a mouse model of glaucoma, mice carrying glaucoma-causing mutation in the MYOC gene could be exposed to additional risk factors or to an increased level of a particular risk factor. Considerable evidence suggests that oxidative stress has an important role in the pathogenesis of glaucoma (56, 57) . Protein misfolding and oxidative stress are closely related events (29) . Accumulation of unfolded proteins in the ER lumens causes oxidative stress, while ROS by itself can cause protein misfolding and the ER (58) . Expression of mutated myocilin sensitizes cells to oxidative stress and leads to cell death, even at low oxidant concentrations, suggesting that oxidative stress, a risk factor and a component of the aging process, together with mutated myocilin may produce more severe glaucoma than any of these factors alone (16) . TM, a tissue that contains high levels of myocilin, is the tissue in the anterior chamber that is most sensitive to oxidative damage (59) . Therefore, the TM may be most sensitive to the synergistic effects of mutated myocilin and oxidative stress. mice. TM cells have a distinct actomyosin cytoskeleton and exhibit considerable contractile properties. The contractility of the actomyosin system in TM cells or the inner wall endothelium of Schlemm's canal is an important determinant in the regulation of outflow resistance (63) . IOP elevation most often appears to be caused by an increased resistance to the outflow of aqueous humor through the drainage structures. The reduced actin fibers observed when alpha-actin positive cells are themselves reduced may lead to a decline in contractility of the actomyosin system and malfunction of the TM, which in turn can cause elevated IOP. We identified much higher IOP in Tg-MYOC Y437H/+ /Sod2 Growing evidence suggests involvement of the ROS in RGC death and axonal degeneration in the retina (56) . For example, a study of homozygous Sod2 knockout mice revealed thinning of the total retina, including nerve fibers and the RGC layer (65) . In the current study, we also identified moderate depletion of the nerve fibers in the retina of Sod2 haplodeficient mice, though this depletion as well as changes in the retinal thickness or the RGC number in 10-to 12-month-old Sod2 haplodeficient mice were not statistically significant. This insinuates that higher levels of ROS in the retina may also contribute to retinal deterioration. As such, RGCs and their axons, when slightly damaged by oxidative stress, may be more vulnerable to mechanical stresses produced by elevated IOP. The depletion in retinal nerve fibers and loss of RGCs in the retina of Tg-MYOC Y437H/+ /Sod2 +/− mice were not evenly distributed throughout the whole retina, just as glaucomatous damage in human patients is not usually evenly distributed. Interestingly, healthy individuals also exhibit varying thickness of retinal nerve fibers, depending on the sector of retina. Sectorial degeneration of axons was similarly observed in the DBA/2J mouse glaucoma model and rat ocular hypertension model (66, 67) . Glaucomatous retinal damage was mainly detected in the peripheral retina of Tg-MYOC Y437H/+ /Sod2 +/− mice.
This observation is compatible with the pattern of disease progression observed in other mouse models of glaucoma (20, 21, 68) and human glaucoma patients, in which glaucoma most often affects peripheral visual function at its early stages, while deterioration of the central retina generally is only seen at the later stages of disease. We believe that the mouse glaucoma model induced by the combination of glaucoma-associated mutated myocilin and a second risk factor (oxidative stress) may more closely mimic the complicated pathogenic mechanisms that arise in human glaucoma patients. It is well established that UV light, ionizing radiation, chemotherapeutics, and environmental toxins are exogenous sources of ROS. Smoking, another cause of high oxidative stress (69) , has been identified as a risk factor in elder women with POAG (70) . Antioxidant drug therapy approaches were suggested and tested for neuroprotection in glaucoma (71) (72) (73) . Antioxidant drug approaches could be also beneficial for patients with glaucoma-causing myocilin mutations who should avoid the substances and behavior such as smoking causing free radical production and may try antioxidants to delay the progression of the disease.
Materials and Methods

Production of double-mutant mice
Heterozygous Sod2 null mice (original strain name: B6.129S7-Sod2 tmlLeb /J) were purchased from the Jackson Laboratories (Bar Harbor, ME). Tg-MYOC Y437H/+ have been previously described (20 
IOP measurement
Mice were anesthetized with a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg). IOP was measured in anesthetized animals using a fiber-optic signal (FTI-10) conditioner equipped with a fiber-optic pressure transducer (FISO Technologies, Montreal, Quebec, Canada) as described previously (20, 21) . The measurements were made from 9 AM to noon. IOP from each eye was 
Immunofluorescent labeling and image analysis
Mouse eyes were fixed in 4% paraformaldehyde for 2 h before processing for cryosection embedding or whole-tissue preparation. Frozen sections (10 μm) of mouse eyes were blocked in a blocking buffer (2% normal goat serum and 0.2% Triton X-100 in PBS) for 1 h and incubated with antibodies against GRP78 (1:100; Cell Signaling Technology), α-SMA (1:200; Abcam, Cambridge, MA) or NFH (1:200; EMD Millipore, Temecula, CA) in a blocking buffer for 3 h, followed by incubation with Alexa 488-conjugated antirabbit secondary antibody (1:500; Life Technologies) for 1 h. Sections were mounted in the ProLong Gold antifade reagent (Life Technologies) or further incubated for 3 h with anti-myocilin antibody which was pre-labeled with DyLight 594 fluorescent dye (74) . Whole eye balls, whole retinas or dissected anterior segments were blocked in a blocking buffer (1% normal goat serum, 1% BSA and 1% Triton X-100 in PBS) for 1 h and incubated with antibodies against α-SMA (1:100; Abcam), NFH (1:200; EMD Millipore), or βIII TUB (1:100; Covance, Berkeley, CA, USA) for 48 h at 4°C, followed by incubation with Alexa 488 (or 555) goat antirabbit secondary antibody (1:500; Life Technologies) or Alexa 488 goat anti-rat secondary antibody (1:500; Life Technologies) for 24 h at 4°C. The mounted samples were examined, and fluorescent images were collected using a Zeiss LSM 700 confocal microscope (Zeiss, Jena, Germany). The images of α-SMA-positive areas in anterior segments were acquired using the tile scan function (1 × 3 tiles). For the quantification of TM cells, TO-PRO-3 (Life Technologies)-stained nuclei in α-SMA-positive TM areas were counted from three randomly selected areas of 50 × 50 μm in the acquired images. The average of three measurements was used to compare different animals. To quantify RGCs, images from each of the four retinal segments were randomly selected to count the number of βIII TUB-positive cells per an area of 375 × 375 μm. The average of the four measurements was used to compare different animals. Fluorescence intensities of the entire NFH-stained wholemount retinas were measured using ZEN Software 2012 (Carl Zeiss). To quantify ELAM-1 fluorescence intensity in TM, TM area was selected and fluorescence quantification was performed as described above. To compare the structures of ONH, confocal z-stacks were collected at 0.271 μm intervals from ONH in the NFH-stained whole retinas. 3D reconstructions from 90 optical sections were performed using Volocity software (PerkinElmer, Waltham, MA, USA). The nerve fiber layer thickness near the ONH was measured using ZEN Software 2012 (Carl Zeiss).
Electron microscopy
Retrobulbar optic nerve segments were double-fixed in 2.5% glutaraldehyde and 0.5% osmium tetroxide in PBS, dehydrated, and embedded in Spurr's epoxy resin. Ultrathin sections (90 nm) were prepared, double-stained with uranyl acetate and lead citrate, and viewed in a JEOL JEM-1010 transmission electron microscope equipped with digital imaging camera.
Statistical analysis
Quantitative data were presented as mean ± S.E. Statistical analysis for two groups was performed using a two-tailed Student's t-test. Statistical analysis for multiple groups was performed with one-way factorial analysis of variance (ANOVA) and subsequent Tukey's multiple comparison test. In all statistical analyses, significance was defined as P < 0.05.
